Home The Word Brain My Amedeo FAQ Privacy About   


As of October 2023, Amedeo had
12,263 active subscribers


  Pulmonary Hypertension, May 2023

Free Subscription


Abstracts

Retrieve all available abstracts of the following 158 articles:
HTML format


 

Single Articles

  1. FIKE CD, Aschner JL
    Pharmacotherapy for Pulmonary Hypertension in Infants with Bronchopulmonary Dysplasia: Past, Present, and Future.
    Pharmaceuticals (Basel). 2023;16:503.
    PubMed    
    Abstract available

  2. TORNLING G, Batta R, Salvail D, Raud J, et al
    Effects of the Oral Angiotensin II Type 2 Receptor Agonist C21 in Sugen-Hypoxia Induced Pulmonary Hypertension in Rats.
    Int J Mol Sci. 2023;24:7478.
    PubMed    
    Abstract available

  3. RICHTER MJ, Tello K
    [Pulmonary hypertension associated with lung disease].
    Herz. 2023 Apr 27. doi: 10.1007/s00059-023-05173.
    PubMed    
    Abstract available

  4. YUCHI Y, Suzuki R, Satomi S, Saito T, et al
    Cardiovascular Effect of Epoprostenol and Intravenous Cardiac Drugs for Acute Heart Failure on Canine Pulmonary Hypertension.
    Vet Sci. 2023;10:302.
    PubMed    
    Abstract available

  5. PROHASKA CC, Zhang X, Schwantes-An TL, Stearman RS, et al
    RASA3 is a candidate gene in sickle cell disease-associated pulmonary hypertension and pulmonary arterial hypertension.
    Pulm Circ. 2023;13:e12227.
    PubMed    
    Abstract available

  6. SCHROEDER L, Holcher S, Leyens J, Geipel A, et al
    Evaluation of levosimendan as treatment option in a large case-series of preterm infants with cardiac dysfunction and pulmonary hypertension.
    Eur J Pediatr. 2023 Apr 27. doi: 10.1007/s00431-023-04971.
    PubMed    
    Abstract available

  7. JAIN N, Sheikh MA, Bajaj D, Townsend W, et al
    Periprocedural Complications With Balloon Pulmonary Angioplasty: Analysis of Global Studies.
    JACC Cardiovasc Interv. 2023;16:976-983.
    PubMed    
    Abstract available

  8. SONNWEBER T, Tymoszuk P, Steringer-Mascherbauer R, Sigmund E, et al
    The combination of supervised and unsupervised learning based risk stratification and phenotyping in pulmonary arterial hypertension-a long-term retrospective multicenter trial.
    BMC Pulm Med. 2023;23:143.
    PubMed    
    Abstract available

  9. PERROS F, Jutant EM, Savale L, Dorfmuller P, et al
    [Physiopathology and treatment of pulmonary arterial hypertension].
    Med Sci (Paris). 2023;39:359-369.
    PubMed    
    Abstract available

  10. QIU F, Jiang B, Lin Y, Li H, et al
    Dual PEDF and HGF Overexpression: A New Therapy for Pulmonary Hypertension.
    Am J Respir Cell Mol Biol. 2023 Apr 24. doi: 10.1165/rcmb.2022-0459.
    PubMed    
    Abstract available

  11. CABELLO-GANEM A, Serrano-Roman J, Espejel-Guzman A, Ramirez-Perea F, et al
    Pulmonary hypertension secondary to Takayasu arteritis and atrial septal defect.
    Clin Rheumatol. 2023 Apr 24. doi: 10.1007/s10067-023-06607.
    PubMed    


  12. RAZEE A, Banerjee S, Hong J, Magaki S, et al
    Thoracic Spinal Cord Neuroinflammation as a Novel Therapeutic Target in Pulmonary Hypertension.
    Hypertension. 2023 Apr 24. doi: 10.1161/HYPERTENSIONAHA.122.20782.
    PubMed    
    Abstract available

  13. PALAZZINI M, Dardi F, Magnani I, Guarino D, et al
    Progress in the treatment of acute pulmonary embolism and chronic thrombo-embolic pulmonary hypertension/disease.
    Eur Heart J Suppl. 2023;25.
    PubMed    
    Abstract available

  14. THOMAS C, Chandel A, King CS, Aryal S, et al
    Prevalence of pulmonary hypertension in patients with COVID-19 related lung disease listed for lung transplantation: A UNOS registry analysis.
    Pulm Circ. 2023;13:e12228.
    PubMed    
    Abstract available

  15. THORE P, Staentzel J, Valentin S, Guillaumot A, et al
    Hemodynamic characteristics in patients with pulmonary hypertension and chronic obstructive pulmonary disease: A retrospective monocentric cohort study.
    Respir Med Res. 2023;83:101008.
    PubMed    
    Abstract available

  16. TOYAMA T, Kudryashova TV, Ichihara A, Lenna S, et al
    GATA6 coordinates cross-talk between BMP10 and oxidative stress axis in pulmonary arterial hypertension.
    Sci Rep. 2023;13:6593.
    PubMed    
    Abstract available

  17. GUAN Y, Jin Y, Lu Y, Ao D, et al
    Correlation of ABO blood groups with treatment response and efficacy in infants with persistent pulmonary hypertension of the newborn treated with inhaled nitric oxide.
    BMC Pregnancy Childbirth. 2023;23:276.
    PubMed    
    Abstract available

  18. SUN M, Gao LJ, Zhang Y, Jing GJ, et al
    Effect of tracheal intubation on postoperative complications in patients with pulmonary hypertension combined with non-cardiothoracic, non-obstetric surgery.
    Medicine (Baltimore). 2023;102:e33635.
    PubMed    
    Abstract available

  19. AKTAA S, Gale CP, Brida M, Giannakoulas G, et al
    European Society of Cardiology quality indicators for the care and outcomes of adults with pulmonary arterial hypertension. Developed in collaboration with the Heart Failure Association of the European Society of Cardiology.
    Eur J Heart Fail. 2023 Mar 16. doi: 10.1002/ejhf.2830.
    PubMed    
    Abstract available

  20. RAHAGHI FF, Trivieri MG, Sahay S
    The role of riociguat in combination therapies for pulmonary arterial hypertension.
    Respir Med. 2023;211:107196.
    PubMed    
    Abstract available

  21. LU Q, Sun X, Yegambaram M, Ornatowski W, et al
    Nitration-mediated activation of the small GTPase RhoA stimulates cellular glycolysis through enhanced mitochondrial fission.
    J Biol Chem. 2023;299:103067.
    PubMed    
    Abstract available

  22. DEL POZO R, Blanco I, Lopez-Meseguer M, Escribano-Subias P, et al
    Effectiveness and persistence with selexipag in pulmonary arterial hypertension in the real-life setting.
    Eur J Intern Med. 2023;111:140-142.
    PubMed    


  23. LIU CW, Le HHT, Denaro Iii P, Dai Z, et al
    E-cigarettes induce dysregulation of autophagy leading to endothelial dysfunction in pulmonary arterial hypertension.
    Stem Cells. 2023 Jan 14:sxad004. doi: 10.1093.
    PubMed    
    Abstract available

  24. GIESINGER RE, Stanford AH, Thomas B, Abman SH, et al
    Safety and Feasibility of Riociguat Therapy for the Treatment of Chronic Pulmonary Arterial Hypertension in Infancy.
    J Pediatr. 2022 Nov 30:S0022-3476(22)01079-4. doi: 10.1016/j.jpeds.2022.
    PubMed    


  25. UNLU S, Bezy S, Cvijic M, Duchenne J, et al
    Right ventricular strain related to pulmonary artery pressure predicts clinical outcome in patients with pulmonary arterial hypertension.
    Eur Heart J Cardiovasc Imaging. 2023;24:635-642.
    PubMed    
    Abstract available

  26. GU Y, Han K, Zhang Z, Zhao Z, et al
    (68)Ga-FAPI PET/CT for molecular assessment of fibroblast activation in right heart in pulmonary arterial hypertension: a single-center, pilot study.
    J Nucl Cardiol. 2022 Mar 23. pii: 10.1007/s12350-022-02952.
    PubMed    
    Abstract available

  27. HUANG H, Lin D, Hu L, Wang J, et al
    QKI Promotes Hypoxia-induced Smooth Muscle Reprogramming in Pulmonary Hypertension.
    Am J Respir Cell Mol Biol. 2023 May 5. doi: 10.1165/rcmb.2022-0349.
    PubMed    
    Abstract available

  28. MCSWEENEY J, Colglazier E, Becerra J, Leary B, et al
    Failure to tolerate continuous subcutaneous treprostinil in pediatric pulmonary hypertension patients.
    Pulm Circ. 2023;13:e12224.
    PubMed    
    Abstract available

  29. HONG C, Chen R, Hu L, Liu H, et al
    Aetiological distribution of pulmonary hypertension and the value of transthoracic echocardiography screening in the respiratory department: A retrospective analysis from China.
    Clin Respir J. 2023 May 4. doi: 10.1111/crj.13623.
    PubMed    
    Abstract available

  30. BRUERA S, Sreedhar A, Agarwal SK, Muthukumar V, et al
    Immunosuppression for the treatment of pulmonary hypertension in patients with systemic lupus erythematosus: A systematic review.
    Int J Rheum Dis. 2023 May 4. doi: 10.1111/1756-185X.14706.
    PubMed    
    Abstract available

  31. BANDORSKI D, Heibel S, Holtgen R, Bogossian H, et al
    Incidence and prognostic significance of malignant arrhythmias during (repetitive) Holter electrocardiograms in patients with pulmonary hypertension.
    Front Cardiovasc Med. 2023;10:1084051.
    PubMed    
    Abstract available

  32. CHOOBDAR FA, Shahhosseini P, Vahedi Z, Khosravi N, et al
    Comparison of the efficacy of inhaled versus infused milrinone in the management of persistent pulmonary hypertension of the newborn in resource-limited settings: A randomized clinical trial.
    Pediatr Pulmonol. 2023 May 3. doi: 10.1002/ppul.26451.
    PubMed    
    Abstract available

  33. PILOTO B, Fernandes CJCDS, Jardim C, Castro M, et al
    Loss of response to calcium channel blockers after long-term follow-up treatment in patients with idiopathic pulmonary arterial hypertension.
    J Bras Pneumol. 2023;49:e20220337.
    PubMed    
    Abstract available

  34. ZHAI Z, Boon GJAM, Staring M, van Dam LF, et al
    Automated quantification of the pulmonary vasculature in pulmonary embolism and chronic thromboembolic pulmonary hypertension.
    Pulm Circ. 2023;13:e12223.
    PubMed    
    Abstract available

  35. KALLONEN J, Corbascio M, Radegran G, Bredin F, et al
    Quality of life and functional status after pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension: A Swedish single-center study.
    Pulm Circ. 2023;13:e12219.
    PubMed    
    Abstract available

  36. YANG X, Yang Y, Liu K, Zhang C, et al
    Traditional Chinese medicine monomers: Targeting pulmonary artery smooth muscle cells proliferation to treat pulmonary hypertension.
    Heliyon. 2023;9:e14916.
    PubMed    
    Abstract available

  37. NABATI M, Parsaee H
    Combined use of double Doppler Tei index and lung ultrasound for predicting pulmonary hypertension and corpulmonale in neonates with respiratory distress.
    J Clin Ultrasound. 2023;51:636-638.
    PubMed    


  38. GAUR J, Singh RK, Kulkarni C, Dube S, et al
    Assessment of Pulmonary Hypertension in Chronic Kidney Disease Patients using Doppler Echocardiography.
    Heart Views. 2023;24:24-28.
    PubMed    
    Abstract available

  39. SIDDAIAH R, Oji-Mmuo C, Aluquin VPR, Kawasawa YI, et al
    Multiomics endotyping of preterm infants with bronchopulmonary dysplasia and pulmonary hypertension-A pilot study.
    Pulm Circ. 2023;13:e12232.
    PubMed    
    Abstract available

  40. CHING S, Yue CS
    A rare cause of pulmonary hypertension in an elderly woman.
    J Geriatr Cardiol. 2023;20:314-316.
    PubMed    


  41. LOGANTHA SJRJ, Yamanushi TT, Absi M, Temple IP, et al
    Remodelling and dysfunction of the sinus node in pulmonary arterial hypertension.
    Philos Trans R Soc Lond B Biol Sci. 2023;378:20220178.
    PubMed    
    Abstract available

  42. ARIMA F
    [Warm autoimmune hemolytic anemia complicated with pulmonary hypertension exhibiting pulmonary mosaic attenuation pattern].
    Rinsho Ketsueki. 2023;64:290-292.
    PubMed    
    Abstract available

  43. SALAZAR AM, Al-Asad KS, Prasad RM, Panama G, et al
    Pulmonary Artery Denervation As A New Therapeutic Option for Pulmonary Hypertension: A Systematic Review and Meta-Analysis.
    Curr Probl Cardiol. 2023 Apr 28:101776. doi: 10.1016/j.cpcardiol.2023.101776.
    PubMed    
    Abstract available

  44. HENDRIKS PM, Staal DP, Pastoor H, Kolpa CIA, et al
    Sexual function is impaired in women and men with pulmonary hypertension.
    Clin Res Cardiol. 2023 Apr 30. doi: 10.1007/s00392-023-02214.
    PubMed    
    Abstract available

  45. ZEITOUNI M, Morlon Q, Silvain J, Procopi N, et al
    Implication of the new definition of pulmonary hypertension in patients evaluated for heart transplantation.
    Int J Cardiol. 2023 Apr 27:S0167-5273(23)00602.
    PubMed    
    Abstract available

  46. LV C, Wu L, Liao G, Huang Y, et al
    Maternal and fetal/neonatal outcomes of pregnancies complicated by pulmonary hypertension: a retrospective study of 154 patients.
    Clinics (Sao Paulo). 2023;78:100194.
    PubMed    
    Abstract available

  47. KAPOOR R, Fatima J, Shukla V
    An Unusual Case of Hyperthyroidism.
    J Assoc Physicians India. 2023;71:1.
    PubMed    
    Abstract available

  48. HARTOPO AB, Anggrahini DW, Dinarti LK, Schafer AK, et al
    Prognostic Value for Mortality of Plasma Bioactive Adrenomedullin in Patients with Pulmonary Arterial Hypertension: A Sub Analysis of the Biomarker Study in the COHARD-PH Registry.
    Medicina (Kaunas). 2023;59:748.
    PubMed    
    Abstract available

  49. WANG D, Gomes MT, Mo Y, Prohaska CC, et al
    Human Endogenous Retrovirus, SARS-CoV-2, and HIV Promote PAH via Inflammation and Growth Stimulation.
    Int J Mol Sci. 2023;24:7472.
    PubMed    
    Abstract available

  50. MONNET X, Lai C
    Which haemodynamic monitoring should we chose for critically ill patients with acute circulatory failure?
    Curr Opin Crit Care. 2023;29:275-280.
    PubMed    
    Abstract available

  51. ZHANG Z, Zheng W, Chen M, Xie Q, et al
    A new risk score for the assessment of outcomes for Chinese patients with peripartum cardiomyopathy.
    Heart Lung. 2023;60:81-86.
    PubMed    
    Abstract available

  52. GONG JN, Mao JJ, Kuang TG, Yang SQ, et al
    Analysis of clinical features between active and inactive patients of Takayasu's arteritis with pulmonary arteries involvement.
    Int J Cardiol. 2023;381:88-93.
    PubMed    
    Abstract available

  53. DENG X, Jiang N, Huang C, Zhou S, et al
    Mortality and prognostic factors in connective tissue disease-associated pulmonary arterial hypertension patients complicated with right heart failure.
    Int J Rheum Dis. 2023;26:862-869.
    PubMed    
    Abstract available

  54. VEITH C, Knoepp F
    Histone Methyl Transferase G9a/GLP-A Novel Avenue in Pulmonary Arterial Hypertension Treatment?
    Am J Respir Cell Mol Biol. 2023;68:475-477.
    PubMed    


  55. KOSTYUNINA DS, Rowan SC, Pakhomov NV, Dillon E, et al
    Shear Stress Markedly Alters the Proteomic Response to Hypoxia in Human Pulmonary Endothelial Cells.
    Am J Respir Cell Mol Biol. 2023;68:551-565.
    PubMed    
    Abstract available

  56. AWADA C, Bourgeois A, Lemay SE, Grobs Y, et al
    G9a/GLP Targeting Ameliorates Pulmonary Vascular Remodeling in Pulmonary Arterial Hypertension.
    Am J Respir Cell Mol Biol. 2023;68:537-550.
    PubMed    
    Abstract available

  57. LEE HW, Adachi T, Pak B, Park S, et al
    BMPR1A promotes ID2-ZEB1 interaction to suppress excessive endothelial to mesenchymal transition.
    Cardiovasc Res. 2023;119:813-825.
    PubMed    
    Abstract available

  58. MARTINEZ-SOLANO J, Ortiz-Bautista C, Gutierrez-Ibanes E, Garcia-Cosio MD, et al
    Optical coherence tomography assessment of pulmonary vascular remodeling in advanced heart failure. The OCTOPUS-CHF study.
    Rev Esp Cardiol (Engl Ed). 2023;76:312-321.
    PubMed    
    Abstract available

  59. FOURNIER E, Selegny M, Amsallem M, Haddad F, et al
    Multiparametric evaluation of right ventricular function in pulmonary arterial hypertension associated with congenital heart disease.
    Rev Esp Cardiol (Engl Ed). 2023;76:333-343.
    PubMed    
    Abstract available

  60. MIRZA M K, Abqari S, Haseen A, Yadav M, et al
    Transcatheter closure of ventricular septal defects: preliminary results in children weighing 10 kg or less.
    Cardiol Young. 2023;33:539-545.
    PubMed    
    Abstract available

  61. PALAZZUOLI A, Savarese G
    An update on diabetes spectrum in heart failure: current evidence and potential therapeutic applications.
    Heart Fail Rev. 2023;28:573-575.
    PubMed    
    Abstract available

  62. ZAMBELAS JM, Karmouty-Quintana H
    Snakes and Ladders: A Potential Therapy of HGF and PEDF in Pulmonary Hypertension.
    Am J Respir Cell Mol Biol. 2023 May 11. doi: 10.1165/rcmb.2023-0118.
    PubMed    


  63. DORONIN DV, Fomichev AV, Agaeva KA, Zhul'kov MO, et al
    [Changes in Pulmonary Hemodynamics Resulted From Long-Term Mechanical Heart Support].
    Kardiologiia. 2023;63:16-21.
    PubMed    
    Abstract available

  64. QUARCK R, Willems L, Tielemans B, Stoian L, et al
    Impairment of Angiogenesis-Driven Clot Resolution Is a Key Event in the Progression to Chronic Thromboembolic Pulmonary Hypertension: Validation in a Novel Rabbit Model.
    Arterioscler Thromb Vasc Biol. 2023 May 11. doi: 10.1161/ATVBAHA.122.317262.
    PubMed    
    Abstract available

  65. CHEN Z, Tian J, Ouyang R
    Clinical characteristics and risk factors for primary Sjogren's syndrome complicated with pulmonary arterial hypertension.
    Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2023;48:339-346.
    PubMed    
    Abstract available

  66. KIELT M, Beer L, Rivera B, Jama W, et al
    Association of the Respiratory Severity Score with Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension in Infants Born Extremely Preterm.
    Res Sq. 2023 Apr 27:rs.3.rs-2852392. doi: 10.21203/rs.3.rs-2852392.
    PubMed    
    Abstract available

  67. YOGESWARAN A, Mamazhakypov A, Schermuly RT, Weiss A, et al
    Erratum to: Right ventricular failure in pulmonary hypertension: recent insights from experimental models.
    Herz. 2023 May 9. doi: 10.1007/s00059-023-05190.
    PubMed    


  68. ANTOUNIANS L, Zani A
    Beyond the diaphragm and the lung: a multisystem approach to understanding congenital diaphragmatic hernia.
    Pediatr Surg Int. 2023;39:194.
    PubMed    
    Abstract available

  69. MAYER M, Badesch DB, Nielsen KH, Kawut S, et al
    Impact of the COVID-19 pandemic on chronic disease management and patient reported outcomes in patients with pulmonary hypertension: The Pulmonary Hypertension Association Registry.
    Pulm Circ. 2023;13:e12233.
    PubMed    
    Abstract available

  70. JAIN S, Yingchoncharoen P, Nugent K
    Effect of Continuous Positive Airway Pressure Therapy in Patient with Obstructive Sleep Apnea and Pulmonary Hypertension: A literature review.
    Cardiol Rev. 2023 May 5. doi: 10.1097/CRD.0000000000000564.
    PubMed    
    Abstract available

  71. COMPAGNONE M, Demola P, Serino F, Masiero G, et al
    [Right heart catheterization in Italian catheterization laboratories: results of the SICI-GISE national survey promoted by the GISE Young Committee].
    G Ital Cardiol (Rome). 2023;24:30-38.
    PubMed    
    Abstract available

  72. KIANI A, Rahimi F, Afaghi S, Paat M, et al
    Association of Upon-Diagnosis Blood Eosinophilic Count with Frequency and Severity of Annual Exacerbation in Chronic Obstructive Pulmonary Disease: A Prospective Longitudinal Analysis.
    Can Respir J. 2023;2023:8678702.
    PubMed    
    Abstract available

  73. ZHANG MQ, Wang CC, Pang XB, Shi JZ, et al
    Role of macrophages in pulmonary arterial hypertension.
    Front Immunol. 2023;14:1152881.
    PubMed    
    Abstract available

  74. LIANG YR, Yang YC, Yang BL, Zeng QX, et al
    [Evaluation effect of COMPERA 2.0 risk assessment model on prognosis of Chinese patients with pulmonary arterial hypertension].
    Zhonghua Yi Xue Za Zhi. 2023;103:1410-1416.
    PubMed    
    Abstract available

  75. BARATTO C, Caravita S, Dewachter C, Faini A, et al
    RIGHT HEART ADAPTATION TO EXERCISE IN PULMONARY HYPERTENSION: AN INVASIVE HEMODYNAMIC STUDY.
    J Card Fail. 2023 May 5:S1071-9164(23)00151.
    PubMed    
    Abstract available

  76. AIMAIER S, Tao Y, Lei F, Yupeng Z, et al
    Protective effects of the Terminalia bellirica tannin-induced Nrf2/HO-1 signaling pathway in rats with high-altitude pulmonary hypertension.
    BMC Complement Med Ther. 2023;23:150.
    PubMed    
    Abstract available

  77. LI F, Wan J, Zhai ZG, Xie WM, et al
    [Clinical features and CT findings of fibrosing mediastinitis associated pulmonary hypertension].
    Zhonghua Jie He He Hu Xi Za Zhi. 2023;46:460-465.
    PubMed    
    Abstract available

  78. TURNER V, Maret E, Kim JB, Codari M, et al
    Reduced Pulmonary Artery Distensibility Predicts Persistent Pulmonary Hypertension and 2-Year Mortality in Patients with Severe Aortic Stenosis Undergoing TAVR.
    Acad Radiol. 2023 May 3:S1076-6332(23)00126-5. doi: 10.1016/j.acra.2023.
    PubMed    
    Abstract available

  79. ABDULKAREEM AO, Tiwari P, Lone ZR, Iqbal H, et al
    Corrigendum to "Ormeloxifene, a selective estrogen receptor modulator, protects against pulmonary hypertension" [Eur. J. Pharmacol. 943 (2023) 175558].
    Eur J Pharmacol. 2023 May 3:175750. doi: 10.1016/j.ejphar.2023.175750.
    PubMed    


  80. PAPADEMETRIOU E, Liu X, Beaudet A, Tsang Y, et al
    Comparative evaluation of costs and healthcare resource utilization of oral selexipag versus inhaled treprostinil or oral treprostinil in patients with pulmonary arterial hypertension.
    J Med Econ. 2023;26:644-655.
    PubMed    
    Abstract available

  81. LIU P, Gao S, Li Z, Pan S, et al
    Endothelial progenitor cell-derived exosomes inhibit pulmonary artery smooth muscle cell in vitro proliferation and resistance to apoptosis by modulating the Mitofusin-2 and Ras-Raf-ERK1/2 signaling pathway.
    Eur J Pharmacol. 2023;949:175725.
    PubMed    
    Abstract available

  82. HYE T, Hossain MR, Saha D, Foyez T, et al
    Emerging biologics for the treatment of pulmonary arterial hypertension.
    J Drug Target. 2023;31:471-485.
    PubMed    
    Abstract available

  83. MA B, Cao Y, Qin J, Chen Z, et al
    Pulmonary artery smooth muscle cell phenotypic switching: A key event in the early stage of pulmonary artery hypertension.
    Drug Discov Today. 2023;28:103559.
    PubMed    
    Abstract available

  84. GHARAHI H, Filonova V, Mullagura HN, Nama N, et al
    A multiscale framework for defining homeostasis in distal vascular trees: applications to the pulmonary circulation.
    Biomech Model Mechanobiol. 2023;22:971-986.
    PubMed    
    Abstract available

  85. PAYNE C, Jacobs S, Shaboodien S, Jumaar C, et al
    A pulmonary arterial hypertension diagnostic algorithm for a third-world context: SYMQUICK.
    J Investig Med. 2023;71:542-544.
    PubMed    


  86. FRANCESCATO G, Capolupo I, Cerbo RM, Doni D, et al
    Reply to the comment on "Fluid restriction in management of patent ductus arteriosus in Italy: a nationwide survey".
    Eur J Pediatr. 2023;182:1931-1932.
    PubMed    
    Abstract available

  87. HE Z
    Comment on "1,8-Cineole ameliorates right ventricle dysfunction associated with pulmonary arterial hypertension by restoring connexin43 and mitochondrial homeostasis".
    Pharmacol Res. 2023;191:106622.
    PubMed    


  88. ALVES-SILVA JM, Zuzarte M, Marques C, Viana S, et al
    Reply to the Comment on "1,8-Cineole ameliorates right ventricle dysfunction associated with pulmonary arterial hypertension by restoring connexin43 and mitochondrial homeostasis".
    Pharmacol Res. 2023;191:106623.
    PubMed    


  89. PARIKH R, Farber HW
    Response to "Noninvasive determinants of pulmonary hypertension (PH) in interstitial lung disease (ILD)" by Joseph et al.
    Pulm Circ. 2023;13:e12239.
    PubMed    


  90. XU W, Deng M, Zhang L, Zhang P, et al
    Qualification of Ventricular Flow in Patients With Precapillary Pulmonary Hypertension With 4-dimensional Flow Magnetic Resonance Imaging.
    J Thorac Imaging. 2023 May 15. doi: 10.1097/RTI.0000000000000715.
    PubMed    
    Abstract available

  91. LIN S, He L, Ji L, Peng Y, et al
    [Analysis on missed diagnosis or misdiagnosis of anomalous origin of left coronary artery from pulmonary artery by echocardiography from one single medical center].
    Zhonghua Xin Xue Guan Bing Za Zhi. 2023;51:481-489.
    PubMed    
    Abstract available

  92. LIU H, Wang S, Chen Q, Ge X, et al
    Natural Targeting Potent ROS-eliminating Tungsten-based Polyoxometalate Nanodots for Efficient Treatment of Pulmonary Hypertension.
    Adv Healthc Mater. 2023 May 17:e2300252. doi: 10.1002/adhm.202300252.
    PubMed    
    Abstract available

  93. PICHON J, Roche A, Fauvel C, Boucly A, et al
    Clinical relevance and prognostic value of renal Doppler in acute decompensated precapillary pulmonary hypertension.
    Eur Heart J Cardiovasc Imaging. 2023 May 17:jead104. doi: 10.1093.
    PubMed    
    Abstract available

  94. RAMADHIANI R, Ikeda K, Miyagawa K, Ryanto GRT, et al
    Endothelial cell senescence exacerbates pulmonary hypertension by inducing juxtacrine Notch signaling in smooth muscle cells.
    iScience. 2023;26:106662.
    PubMed    
    Abstract available

  95. KRZYZEWSKA A, Baranowska-Kuczko M, Kasacka I, Kozlowska H, et al
    Cannabidiol alleviates right ventricular fibrosis by inhibiting the transforming growth factor beta pathway in monocrotaline-induced pulmonary hypertension in rats.
    Biochim Biophys Acta Mol Basis Dis. 2023;1869:166753.
    PubMed    
    Abstract available

  96. WIEDENROTH CB, Pruefer D, Adameit MSD, Mayer E, et al
    Chronic thromboembolic pulmonary hypertension-medical, interventional, and surgical therapy.
    Herz. 2023 Apr 25. doi: 10.1007/s00059-023-05172.
    PubMed    
    Abstract available

  97. NIELSEN R, Christensen KH, Gopalasingam N, Berg-Hansen K, et al
    Hemodynamic Effects of Ketone Bodies in Patients With Pulmonary Hypertension.
    J Am Heart Assoc. 2023;12:e028232.
    PubMed    
    Abstract available

  98. LI Y, Zhang R, Shan H, Shi W, et al
    FVC/D(LCO) identifies pulmonary hypertension and predicts 5-year all-cause mortality in patients with COPD.
    Eur J Med Res. 2023;28:174.
    PubMed    
    Abstract available

  99. JOSEPH P, Savarimuthu S, Oakland HT, Cullinan M, et al
    Response to letter to the editor "noninvasive determinants of pulmonary hypertension in interstitial lung disease".
    Pulm Circ. 2023;13:e12238.
    PubMed    


  100. KURAMOTO K, Ogawa A, Kiyama K, Matsubara H, et al
    Antiproliferative effect of selexipag active metabolite MRE-269 on pulmonary arterial smooth muscle cells from patients with chronic thromboembolic pulmonary hypertension.
    Pulm Circ. 2023;13:e12231.
    PubMed    
    Abstract available

  101. KIM BJ, Kim SJ, Im SI, Kim H, et al
    Pulmonary Hypertension With Unilateral Pulmonary Vein Atresia.
    Int J Heart Fail. 2023;5:102-105.
    PubMed    


  102. CHARIFA A, Olivier B, Steeve P, Sebastien B, et al
    The future of group 2 pulmonary hypertension: Exploring clinical trials and therapeutic targets.
    Vascul Pharmacol. 2023 May 11:107180. doi: 10.1016/j.vph.2023.107180.
    PubMed    
    Abstract available

  103. ANDERSEN S, Reese-Petersen AL, Braams N, Andersen MJ, et al
    Biomarkers of collagen turnover and wound healing in chronic thromboembolic pulmonary hypertension patients before and after pulmonary endarterectomy.
    Int J Cardiol. 2023 May 11:S0167-5273(23)00706.
    PubMed    
    Abstract available

  104. HAVRANEK S, Fingrova Z, Skala T, Reichenbach A, et al
    Catheter ablation of atrial fibrillation and atrial tachycardia in patients with pulmonary hypertension: a randomized study.
    Europace. 2023 May 13:euad131. doi: 10.1093.
    PubMed    
    Abstract available

  105. HU H, Cai J, Qi D, Li B, et al
    Identification of Potential Biomarkers for Group I Pulmonary Hypertension Based on Machine Learning and Bioinformatics Analysis.
    Int J Mol Sci. 2023;24:8050.
    PubMed    
    Abstract available

  106. VALENTINI A, Franchi P, Cicchetti G, Messana G, et al
    Pulmonary Hypertension in Chronic Lung Diseases: What Role Do Radiologists Play?
    Diagnostics (Basel). 2023;13:1607.
    PubMed    
    Abstract available

  107. GREDIC M, Karnati S, Ruppert C, Guenther A, et al
    Combined Pulmonary Fibrosis and Emphysema: When Scylla and Charybdis Ally.
    Cells. 2023;12:1278.
    PubMed    
    Abstract available

  108. FAIRLEY JL, Hansen D, Ross L, Proudman S, et al
    Clinical characteristics and survival of pulmonary arterial hypertension with or without interstitial lung disease in systemic sclerosis.
    Arthritis Res Ther. 2023;25:77.
    PubMed    
    Abstract available

  109. BOBHATE P, Gupta RK, Karande T, Kulkarni S, et al
    Inhaled iloprost as an add-on therapy for advanced pulmonary arterial hypertension: An Indian perspective.
    Natl Med J India. 2023;35:338-343.
    PubMed    
    Abstract available

  110. MOHANKUMAR N, Namboodiri N, Nair KKM, Raghuram K, et al
    Study of atrial arrhythmias after surgical or device closure of atrial septal defect.
    Natl Med J India. 2023;35:271-275.
    PubMed    
    Abstract available

  111. CHEN A, Gao G, Lian G, Gong J, et al
    Zinc promotes cell proliferation via regulating metal-regulatory transcription factor 1 expression and transcriptional activity in pulmonary arterial hypertension.
    Cell Cycle. 2023;22:1284-1301.
    PubMed    
    Abstract available

  112. LIANG WL, Liang B
    Soluble Guanylate Cyclase Activators and Stimulators in Patients with Heart Failure.
    Curr Cardiol Rep. 2023;25:607-613.
    PubMed    
    Abstract available

  113. ZHANG C, Tsang Y, He J, Panjabi S, et al
    Predicting Risk of 1-Year Hospitalization Among Patients with Pulmonary Arterial Hypertension.
    Adv Ther. 2023;40:2481-2492.
    PubMed    
    Abstract available

  114. BO B, Pugnaloni F, Licari A, Patel N, et al
    Ductus arteriosus flow predicts outcome in neonates with congecsion.
    Pediatr Pulmonol. 2023 Mar 15. doi: 10.1002/ppul.26385.
    PubMed    
    Abstract available

  115. MATSUSHITA FY, Krebs VLJ, de Carvalho WB
    Identifying two distinct subphenotypes of patent ductus arteriosus in preterm infants using machine learning.
    Eur J Pediatr. 2023 Feb 28. doi: 10.1007/s00431-023-04882.
    PubMed    
    Abstract available

  116. BEGHETTI M, Ivy D, Scott N, Machlitt-Northen S, et al
    Letter to the Editor, regarding Li L, Zhu X, Chen X, Gao J, Ding C, et al. Advances in targeted therapy for pulmonary arterial hypertension in children. Eur J Pediatr. 2022 Dec 17.
    Eur J Pediatr. 2023;182:2453-2454.
    PubMed    


  117. LI L, Ning J, Ma S
    Correspondence, letter to the editor regarding Li L, Zhu X, Chen X, Gao J, Ding C, et al. Advances in targeted therapy for pulmonary arterial hypertension in children. Eur J Pediatr. 2022 Dec 17.
    Eur J Pediatr. 2023;182:2455.
    PubMed    


  118. ARWAS N, Goldbart A, Aviram M, Dizitzer Y, et al
    Flexible bronchoscopy in pediatric patients with Down syndrome: A case-control study of the indications, findings, and complications.
    Pediatr Pulmonol. 2023;58:1658-1664.
    PubMed    
    Abstract available

  119. LENARDUZZI S, Spedicati B, Alessandrini B, Tesolin P, et al
    Whole-exome sequencing: Clinical characterization of pediatric and adult Italian patients affected by different forms of hereditary cardiovascular diseases.
    Mol Genet Genomic Med. 2023;11:e2143.
    PubMed    
    Abstract available

  120. LI L, Zhu X, Chen X, Gao J, et al
    Advances in targeted therapy for pulmonary arterial hypertension in children.
    Eur J Pediatr. 2023;182:2067-2076.
    PubMed    
    Abstract available

  121. YOGESWARAN A, Richter MJ, Husain-Syed F, Rako Z, et al
    Estimated plasma volume status: association with congestion, cardiorenal syndrome and prognosis in precapillary pulmonary hypertension.
    Front Cardiovasc Med. 2023;10:1161041.
    PubMed    
    Abstract available

  122. TING YH, Yu MW, Wu YJ, Wu SH, et al
    Long-Term Experience and Safety of Transitioning from Subcutaneous Treprostinil to Oral Selexipag in the High-Risk Pulmonary Hypertension Patient: A Case Report.
    Acta Cardiol Sin. 2023;39:492-496.
    PubMed    


  123. KHAN A, Ubaid A, Hanif M, Jaiswal V, et al
    An interesting case of pulmonary hypertension in nephrotic syndrome due to amphetamine use for attention-deficit hyperactivity disorder.
    Ann Med Surg (Lond). 2023;85:1874-1877.
    PubMed    
    Abstract available

  124. SCHROEDER L, Monno P, Strizek B, Dresbach T, et al
    Intravenous sildenafil for treatment of early pulmonary hypertension in preterm infants.
    Sci Rep. 2023;13:8405.
    PubMed    
    Abstract available

  125. XIONG C, Yang B
    Revising the hemodynamic criteria for pulmonary hypertension: A perspective from China.
    J Transl Int Med. 2023;11:1-3.
    PubMed    


  126. SERATI A, Keshmiri MS, Shafaghi S, Mohammad MM, et al
    The Outcome of Patients with Pulmonary Arterial Hypertension and Chronic Thromboembolic Pulmonary Hypertension during the COVID-19 Pandemic.
    Crit Pathw Cardiol. 2023;22:60-64.
    PubMed    
    Abstract available

  127. ZHANG M, Xie W, Xiao Y, Guo W, et al
    Current status of diagnosis and treatment of pulmonary hypertension in Chinese tertiary hospitals: A nationwide survey.
    Pulm Circ. 2023;13:e12241.
    PubMed    
    Abstract available

  128. YE Y, Xu Q, Wuren T
    Inflammation and immunity in the pathogenesis of hypoxic pulmonary hypertension.
    Front Immunol. 2023;14:1162556.
    PubMed    
    Abstract available

  129. JANDL K, Radic N, Zeder K, Kovacs G, et al
    Pulmonary vascular fibrosis in pulmonary hypertension - The role of the extracellular matrix as a therapeutic target.
    Pharmacol Ther. 2023 May 18:108438. doi: 10.1016/j.pharmthera.2023.108438.
    PubMed    
    Abstract available

  130. THAPA KB, Paudel A, Dhital S, Shrestha A, et al
    Polycythemia among Patients with Chronic Obstructive Pulmonary Disease Admitted to the Department of Medicine in a Tertiary Care Center: A Descriptive Cross-sectional Study.
    JNMA J Nepal Med Assoc. 2023;61:343-346.
    PubMed    
    Abstract available

  131. LI H, Yu Y, Wang Y, Zhang Q, et al
    Prognostic Risk Factors of 30-Day Death in Traumatic Lower Limb Fracture Patients with Acute Pulmonary Embolism: A Single-Center Retrospective Study.
    Can Respir J. 2023;2023:8246730.
    PubMed    
    Abstract available

  132. MA H, Yu Y, Mo L, Chen Q, et al
    Exosomal miR-663b from "M1" macrophages promotes pulmonary artery vascular smooth muscle cell dysfunction through inhibiting the AMPK/Sirt1 axis.
    Aging (Albany NY). 2023;15:3549-3571.
    PubMed    
    Abstract available

  133. MA Q, Wang M, Li L, Zhang X, et al
    Jiedu Quyu Decoction mitigates monocrotaline-induced right-sided heart failure associated with pulmonary artery hypertension by inhibiting NLRP3 inflammasome in rats.
    J Ethnopharmacol. 2023;313:116556.
    PubMed    
    Abstract available

  134. YOSHIDA S, Kreger AM, Shaik IH, West RE 3rd, et al
    Intra-amniotic sildenafil administration in rabbits: Safety, pharmacokinetics, organ distribution and histologic evaluation.
    Toxicol Appl Pharmacol. 2023;469:116527.
    PubMed    
    Abstract available

  135. ALAMRI AK, Ma CL, Ryan JJ
    Novel Drugs for the Treatment of Pulmonary Arterial Hypertension: Where Are We Going?
    Drugs. 2023;83:577-585.
    PubMed    
    Abstract available

  136. NAKAMURA Y, Hoashi T, Imai K, Okuda N, et al
    Patient-prosthesis mismatch associated with somatic growth after mechanical mitral valve replacement in small children: metrics for reoperation and outcomes.
    Semin Thorac Cardiovasc Surg. 2022 Apr 14. pii: S1043-0679(22)00076.
    PubMed    
    Abstract available

  137. MUKHERJEE M, Ogunmoroti O, Jani V, Kapoor K, et al
    Characteristics of Right Ventricular to Pulmonary Arterial Coupling and Association With Functional Status Among Older Aged Adults from the Multi-Ethnic Study of Atherosclerosis.
    Am J Cardiol. 2023;196:41-51.
    PubMed    
    Abstract available

  138. BONNESEN K, Klok FA, Andersen MJ, Andersen A, et al
    Long-Term Prognostic Impact of Pulmonary Hypertension After Venous Thromboembolism.
    Am J Cardiol. 2023 May 16:S0002-9149(23)00236.
    PubMed    
    Abstract available

  139. FORTUNI F, Delgado V
    Gender and Age Differences in Right Ventricular to Pulmonary Arterial Coupling in Healthy Subjects - Knowing the Norm to Spot the Disease.
    Am J Cardiol. 2023;197:84-86.
    PubMed    


  140. DOUGHERTY EJ, Chen LY, Awad KS, Ferreyra GA, et al
    Inflammation and DKK1-induced AKT activation contribute to endothelial dysfunction following NR2F2 loss.
    Am J Physiol Lung Cell Mol Physiol. 2023;324:L783-L798.
    PubMed    
    Abstract available

  141. BRUSATORI S, Zinnato C, Busana M, Romitti F, et al
    High- versus Low-Flow Extracorporeal Respiratory Support in Experimental Hypoxemic Acute Lung Injury.
    Am J Respir Crit Care Med. 2023;207:1183-1193.
    PubMed    
    Abstract available

  142. NATHAN SD
    Progress in the Treatment of Pulmonary Hypertension Associated with Interstitial Lung Disease.
    Am J Respir Crit Care Med. 2023 May 9. doi: 10.1164/rccm.202212-2342.
    PubMed    
    Abstract available

  143. QUARCK R, Bogaard HJ, Delcroix M
    The Cellular Landscape of Chronic Thromboembolic Pulmonary Hypertension Revealed by Single-Cell Sequencing: Therapeutic Implications?
    Am J Respir Crit Care Med. 2023;207:1266-1268.
    PubMed    


  144. MENG ML, Fuller M, Federspiel JJ, Engelhard M, et al
    Maternal Morbidity According to Mode of Delivery Among Pregnant Patients With Pulmonary Hypertension.
    Anesth Analg. 2023 May 16. doi: 10.1213/ANE.0000000000006523.
    PubMed    
    Abstract available

  145. SCARPATO BM, McDonald J, Bayrak-Toydemir P, Elliott CG, et al
    The Shunt of It.
    Chest. 2023;163:e201-e205.
    PubMed    
    Abstract available

  146. THENAPPAN T, Brittain EL
    Right Ventricular Imaging for Predicting Risk in Pulmonary Arterial Hypertension: The Elephant in the Room.
    Chest. 2023;163:1013-1015.
    PubMed    


  147. EL-KERSH K, Zhao C, Elliott G, Farber HW, et al
    Derivation of a Risk Score (REVEAL-ECHO) Based on Echocardiographic Parameters of Patients With Pulmonary Arterial Hypertension.
    Chest. 2023;163:1232-1244.
    PubMed    
    Abstract available

  148. JANI V, Aslam MI, Fenwick AJ, Ma W, et al
    Right Ventricular Sarcomere Contractile Depression and the Role of Thick Filament Activation in Human Heart Failure With Pulmonary Hypertension.
    Circulation. 2023 May 17. doi: 10.1161/CIRCULATIONAHA.123.064717.
    PubMed    
    Abstract available


  149. Correction to: Gremlin Plays a Key Role in the Pathogenesis of Pulmonary Hypertension.
    Circulation. 2023;147:e718.
    PubMed    


  150. MORENO P, Alvarez A
    Living-Donor Lobar Lung Transplantation: A Powerful BUT Still Undervalued Resource To Overcome Donor Shortage.
    Eur J Cardiothorac Surg. 2023 Mar 16:ezad081. doi: 10.1093.
    PubMed    


  151. SCHMIDT KH, Milger K, Pausch C, Huscher D, et al
    Trends in COVID-19-associated mortality in patients with pulmonary hypertension: a COMPERA analysis.
    Eur Respir J. 2023;61:2202440.
    PubMed    
    Abstract available

  152. DE MAN FS, Vonk Noordegraaf A
    The right ventricle tamed.
    Eur Respir J. 2023;61:2300509.
    PubMed    


  153. SAMARANAYAKE CB, Kempny A, Naeije R, Gatzoulis M, et al
    Beta-blockade improves right ventricular diastolic function in exercising pulmonary arterial hypertension.
    Eur Respir J. 2023;61:2300144.
    PubMed    
    Abstract available

  154. CRAMARIUC D, Urheim S
    Pulmonary hypertension in significant aortic valve disease: a dive into real-world data.
    Heart. 2023 Apr 24:heartjnl-2023-322495. doi: 10.1136/heartjnl-2023-322495.
    PubMed    


  155. NAG P, Chowdhury SR, Behera SK, Das M, et al
    Levosimendan or Milrinone for Ventricular Septal Defect Repair With Pulmonary Arterial Hypertension.
    J Cardiothorac Vasc Anesth. 2023;37:972-979.
    PubMed    
    Abstract available

  156. ASHWIN REDDY S, Swietlik EM, Robertson L, Michael A, et al
    Natural History of Chronic Thromboembolic Pulmonary Disease with no or mild Pulmonary Hypertension.
    J Heart Lung Transplant. 2023 May 16:S1053-2498(23)01848.
    PubMed    
    Abstract available

  157. NARULA T, Martin AK, Asif AA, Fritz AV, et al
    Outcomes of Lung Transplantation in Patients With Combined Pulmonary Fibrosis and Emphysema: A Single-Center Experience.
    Transplant Proc. 2023 Feb 25:S0041-1345(23)00003.
    PubMed    
    Abstract available

  158. GODA A, Yanagisawa Y, Takeuchi S, Takeuchi K, et al
    Characteristics of cardiopulmonary exercise testing in patients with combined post- and pre-capillary pulmonary hypertension due to left heart disease.
    PLoS One. 2023;18:e0286057.
    PubMed    
    Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Pulmonary Hypertension is free of charge.


;